Prescription drug · NDA
Temazepam NDC 68084-549
Temazepam 7.5 mg/1 · Capsule · Oral · American Health Packaging
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68084-549-21 | 68084054921 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-549-21) / 1 CAPSULE in 1 BLISTER PACK (68084-549-11)Marketed from Aug 1, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Temazepam
- Generic name (nonproprietary)
- temazepam
- Active ingredients
- Temazepam — 7.5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- American Health PackagingNDC labeler code 68084
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018163
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 68084-549_437ec164-740f-2419-e063-6294a90a17e6SPL ID 437ec164-740f-2419-e063-6294a90a17e6SPL set ID a3f06243-fa03-4cbd-951a-144ec43dcdfdRxCUI 198243UNII CHB1QD2QSS
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468084054921followed by a unit qualifier and the quantityPackage 68084-0549-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Temazepam Capsules USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Temazepam Capsules USP should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.
Excerpt only. Read the full label for complete information.
About NDC 68084-549
- What is NDC 68084-549?
- 68084-549 is the product NDC for Temazepam, Temazepam 7.5 mg/1 capsule, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Temazepam.
- What is the active ingredient?
- Temazepam.
- Who is the labeler?
- American Health Packaging, NDC labeler code 68084. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Temazepam?
- 83 other product NDCs are listed under this name. See all Temazepam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Temazepam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-556 | 53746-0556-0153746-0556-05 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-557 | 53746-0557-0153746-0557-05 |
| temazepam | Temazepam 15 mg/1 | CapsuleOral | AvPAK | 50268-779 | 50268-0779-15 |
| temazepam | Temazepam 30 mg/1 | CapsuleOral | AvPAK | 50268-780 | 50268-0780-13 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8493 | 68788-8493-03 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0295 | 80425-0295-0180425-0295-0280425-0295-03 |
| Temazepam | Temazepam 7.5 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-611 | 43547-0611-10 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-612 | 43547-0612-1043547-0612-50 |
| Temazepam | Temazepam 22.5 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-613 | 43547-0613-03 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-614 | 43547-0614-1043547-0614-50 |
Other NDCs under NDA 018163
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Restoriltemazepam | Temazepam 22.5 mg/1 | CapsuleOral | SpecGx LLC | 0406-9914 |
| Restoriltemazepam | Temazepam 7.5 mg/1 | CapsuleOral | SpecGx LLC | 0406-9915 |
| Restoriltemazepam | Temazepam 15 mg/1 | CapsuleOral | SpecGx LLC | 0406-9916 |
| Restoriltemazepam | Temazepam 30 mg/1 | CapsuleOral | SpecGx LLC | 0406-9917 |
| Temazepam | Temazepam 7.5 mg/1 | CapsuleOral | SpecGx LLC | 0406-9960 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | SpecGx LLC | 0406-9961 |
| Temazepam | Temazepam 7.5 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-004 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | SpecGx LLC | 0406-9962 |
| Temazepam | Temazepam 22.5 mg/1 | CapsuleOral | SpecGx LLC | 0406-9959 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-625 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-626 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-449 |